| BPD + PH group | BPD alone | Test value | P-value | Sig. | |
No. = 45 | No. = 45 | |||||
Gestational age (wks) | Mean ± SD | 33.47 ± 3.81 | 35.40 ± 3.31 | −2.571• | 0.012 | S |
Range | 26 - 41 | 30 - 40 | ||||
Birth Weight (BW)(kg) | Mean ± SD | 2.40 ± 0.95 | 2.80 ± 0.85 | −2.059• | 0.042 | S |
Range | 0.87 - 4.6 | 1.5 - 4.5 | ||||
Gender | Male | 24 (53.3%) | 24 (53.3%) | 0.000* | 1.000 | NS |
Female | 21 (46.7%) | 21 (46.7%) | ||||
Mode of Delivery | Vaginal delivery | 15 (33.3%) | 20 (44.4%) | 1.169* | 0.280 | NS |
Cesarean delivery | 30 (66.7%) | 25 (55.6%) | ||||
Period of hospital stay | Mean ± SD | 51.09 ± 16.30 | 40.82 ± 12.82 | 3.321• | 0.001 | HS |
Range | 28 - 97 | 29 - 84 | ||||
APGAR Score At 1 min | Median (IQR) | 6 (5 - 8) | 8 (6 - 8) | −1.320#: | 0.187 | NS |
Range | 3 - 9 | 3 - 9 | ||||
APGAR Score At 5 min | Median (IQR) | 9 (8 - 9) | 9 (8 - 9) | −1.434#: | 0.151 | NS |
Range | 6 - 10 | 7 - 10 | ||||
Need For Active Resuscitation | Initial steps | 18 (40.0%) | 17 (37.8%) | 5.171* | 0.270 | NS |
PPV | 3 (6.7%) | 9 (20.0%) | ||||
ET | 14 (31.1%) | 14 (31.1%) | ||||
Compression | 4 (8.9%) | 3 (6.7%) | ||||
Medication | 6 (13.3%) | 2 (4.4%) | ||||
Administration of surfactant | No | 26 (57.8%) | 15 (33.3%) | 11.951* | 0.002 | HS |
One dose | 15 (33.3%) | 30 (66.7%) | ||||
Two doses | 4 (8.9%) | 0 (0.0%) | ||||
Patent ducts arteriosus | Yes | 18 (40.0%) | 14 (31.1%) | 0.776* | 0.378 | NS |
No | 27 (60.0%) | 31 (68.9%) | ||||
Age in days at Sampling | Mean ± SD | 28.70 ± 3.62 | 27.52 ± 1.66 | 1.531• | 0.131 | NS |
Range | 23 - 40 | 23 - 30 | ||||
Grades of BPD | Mild | 2 (0.04%) | 23 (51.1%) | 8.349* | 0.015 | S |
Moderate | 15 (33.3%) | 14 (31.1%) | ||||
Severe | 28 (62.2%) | 8 (17.7%) |